Fractyl Health, Inc. (GUTS)
NASDAQ: GUTS · Real-Time Price · USD
0.656
+0.003 (0.49%)
At close: Apr 28, 2026, 4:00 PM EDT
0.660
+0.004 (0.55%)
After-hours: Apr 28, 2026, 7:36 PM EDT
Fractyl Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | - | 0.09 | 0.12 | - | - | |
| Revenue Growth (YoY) | - | -22.50% | - | - | - | |
| Cost of Revenue | - | 0.05 | 0.08 | - | - | |
| Gross Profit | - | 0.04 | 0.04 | - | - | |
| Selling, General & Admin | 22.28 | 23.1 | 12.84 | 15.03 | 10.49 | |
| Research & Development | 74.54 | 70.47 | 38.04 | 34.35 | 26.44 | |
| Operating Expenses | 96.82 | 93.57 | 50.88 | 49.39 | 36.93 | |
| Operating Income | -96.82 | -93.53 | -50.84 | -49.39 | -36.93 | |
| Interest Expense | - | - | - | - | -1.46 | |
| Interest & Investment Income | 1.54 | 4.15 | 1.26 | 0.8 | 0.02 | |
| Other Non Operating Income (Expenses) | -40.95 | 17.86 | -6.82 | 0.13 | -0.37 | |
| EBT Excluding Unusual Items | -136.23 | -71.52 | -56.39 | -48.46 | -38.74 | |
| Other Unusual Items | -4.72 | 2.83 | -20.7 | 2 | - | |
| Pretax Income | -140.95 | -68.69 | -77.09 | -46.45 | -38.74 | |
| Net Income | -140.95 | -68.69 | -77.09 | -46.45 | -38.74 | |
| Preferred Dividends & Other Adjustments | - | 1.74 | 17.18 | 17.18 | 14.49 | |
| Net Income to Common | -140.95 | -70.43 | -94.27 | -63.63 | -53.22 | |
| Shares Outstanding (Basic) | 76 | 44 | 2 | 2 | 2 | |
| Shares Outstanding (Diluted) | 76 | 44 | 2 | 2 | 2 | |
| Shares Change (YoY) | 74.13% | 1992.01% | 4.57% | 7.03% | 0.90% | |
| EPS (Basic) | -1.86 | -1.62 | -45.29 | -31.97 | -28.62 | |
| EPS (Diluted) | -1.86 | -1.62 | -45.29 | -31.97 | -28.62 | |
| Free Cash Flow | -90.89 | -67.29 | -43.18 | -46.3 | -33.51 | |
| Free Cash Flow Per Share | -1.20 | -1.54 | -20.75 | -23.26 | -18.02 | |
| Gross Margin | - | 46.24% | 35.83% | - | - | |
| Operating Margin | - | -100570.97% | -42363.33% | - | - | |
| Profit Margin | - | -75732.26% | -78559.17% | - | - | |
| Free Cash Flow Margin | - | -72350.54% | -35985.00% | - | - | |
| EBITDA | -95.69 | -92.85 | -50.55 | -48.93 | -36.25 | |
| D&A For EBITDA | 1.13 | 0.68 | 0.29 | 0.45 | 0.68 | |
| EBIT | -96.82 | -93.53 | -50.84 | -49.39 | -36.93 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.